Prediction of enterococcal imipenem susceptibility using ampicillin or penicillin MICs: more evidence for a class concept.
作者信息
Jones R N
出版信息
J Clin Microbiol. 2001 Oct;39(10):3810-1. doi: 10.1128/JCM.39.10.3810-3811.2001.
Abstract
摘要
相似文献
1
Prediction of enterococcal imipenem susceptibility using ampicillin or penicillin MICs: more evidence for a class concept.使用氨苄西林或青霉素的最低抑菌浓度预测肠球菌对亚胺培南的敏感性：关于类别概念的更多证据
J Clin Microbiol. 2001 Oct;39(10):3810-1. doi: 10.1128/JCM.39.10.3810-3811.2001.
2
Ampicillin-sensitive, imipenem-resistant strains of Enterococcus faecium.
J Clin Microbiol. 2002 Feb;40(2):738. doi: 10.1128/JCM.40.2.738.2002.
3
Multicenter evaluation of use of penicillin and ampicillin as surrogates for in vitro testing of susceptibility of enterococci to imipenem.以青霉素和氨苄西林作为替代物对肠球菌进行亚胺培南体外药敏试验的多中心评估。
J Clin Microbiol. 2004 Aug;42(8):3747-51. doi: 10.1128/JCM.42.8.3747-3751.2004.
4
Evaluation of Vitek system for susceptibility testing of Enterococcus faecium isolates.
Ann Clin Lab Sci. 2004 Winter;34(1):83-6.
5
Spread of an unusual penicillin- and imipenem-resistant but ampicillin-susceptible phenotype among Enterococcus faecalis clinical isolates.一种不寻常的对青霉素和亚胺培南耐药但对氨苄西林敏感的表型在粪肠球菌临床分离株中的传播。
J Antimicrob Chemother. 2006 Jan;57(1):158-60. doi: 10.1093/jac/dki427. Epub 2005 Nov 24.
6
Evaluation of Enterococcus faecalis clinical isolates with 'penicillin-resistant, ampicillin-susceptible' phenotype as reported by Vitek-2 Compact system.对Vitek-2 Compact系统报告的具有“耐青霉素、对氨苄西林敏感”表型的粪肠球菌临床分离株的评估。
Pathology. 2014 Oct;46(6):544-50. doi: 10.1097/PAT.0000000000000146.
7
The comparative in vitro activity of clinafloxacin and other antimicrobials against vancomycin-susceptible and vancomycin-resistant enterococci.克林沙星与其他抗菌药物对万古霉素敏感和耐药肠球菌的体外比较活性。
Chemotherapy. 1996 Jul-Aug;42(4):235-9. doi: 10.1159/000239449.
8
[Isolation rate of Enterococcus spp. from surgical infections and their susceptibilities].
Jpn J Antibiot. 1997 May;50(5):460-73.
9
Synergistic effect of gentamicin plus ampicillin on enterococci.
Diagn Microbiol Infect Dis. 2001 Feb;39(2):137-8. doi: 10.1016/s0732-8893(00)00225-x.
10
Increased bactericidal activity as documented by serum bactericidal titers for a triple combination of cell wall active agents against gentamicin-resistant enterococci.针对庆大霉素耐药肠球菌，细胞壁活性剂三联组合的血清杀菌效价所证明的杀菌活性增强。
Scand J Infect Dis. 1995;27(4):401-3. doi: 10.3109/00365549509032740.
引用本文的文献
1
Endophthalmitis caused by Enterococcus mundtii.蒙氏肠球菌引起的眼内炎。
J Clin Microbiol. 2005 Mar;43(3):1475-6. doi: 10.1128/JCM.43.3.1475-1476.2005.
本文引用的文献
1
Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.对万古霉素敏感和耐药的粪肠球菌和屎肠球菌，青霉素、氨苄西林和亚胺培南的最低抑菌浓度（MIC）及药敏折点的比较评估
J Clin Microbiol. 2001 Jul;39(7):2729-31. doi: 10.1128/JCM.39.7.2729-2731.2001.
2
Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999.肠球菌的临床患病率、抗菌药物敏感性及地域耐药模式：1997 - 1999年哨兵抗菌监测计划的结果
Clin Infect Dis. 2001 May 15;32 Suppl 2:S133-45. doi: 10.1086/320185.
3
Susceptibility of enterococci and Listeria monocytogenes to N-Formimidoyl thienamycin alone and in combination with an aminoglycoside.肠球菌和单核细胞增生李斯特菌对单独使用及与氨基糖苷类联合使用的N-亚胺基噻烯霉素的敏感性。
Antimicrob Agents Chemother. 1981 May;19(5):789-93. doi: 10.1128/AAC.19.5.789.
4
Interpretive standards and quality control guidelines for imipenem susceptibility tests with 10-micrograms disks.使用10微克纸片进行亚胺培南药敏试验的解释标准和质量控制指南。
J Clin Microbiol. 1984 Nov;20(5):988-9. doi: 10.1128/jcm.20.5.988-989.1984.
5
Review of the in vitro spectrum of activity of imipenem.亚胺培南体外活性谱的综述。
Am J Med. 1985 Jun 7;78(6A):22-32. doi: 10.1016/0002-9343(85)90098-1.
6
Pathogenesis and treatment of endocarditis.心内膜炎的发病机制与治疗
Am J Med. 1985 Jun 7;78(6A):127-33. doi: 10.1016/0002-9343(85)90115-9.
7
Treatment of skin and soft tissue infections with imipenem/cilastatin.
Am J Med. 1985 Jun 7;78(6A):110-2. doi: 10.1016/0002-9343(85)90111-1.
8
Imipenem/cilastatin therapy of bacteremia.
Am J Med. 1985 Jun 7;78(6A):95-9. doi: 10.1016/0002-9343(85)90108-1.
9
Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.亚胺培南/西司他丁。对其抗菌活性、药代动力学特性及治疗效果的综述。
Drugs. 1987 Mar;33(3):183-241. doi: 10.2165/00003495-198733030-00001.
10
Tentative interpretive criteria for in vitro antibacterial susceptibility testing with imipenem.亚胺培南体外抗菌药敏试验的暂行解释标准。
J Clin Microbiol. 1986 Mar;23(3):421-4. doi: 10.1128/jcm.23.3.421-424.1986.
Zotero 插件